Innate Pharma S.A.

OTC
IPHYF
Stock
Yield per half year: -40.17%
Dividend yield: 0%
Sector: Healthcare

Innate Pharma S.A.

3.133.132.522.521.901.901.281.28Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 54.24 -100% -15.14 -100%
P/S 17.86 4.62 286.45%
P/BV 25.51 4.2 507.9%
P/FCF 0 16.2 -100%
Ev/Ebitda -4.05 14.71 -127.54%
Ev/S 15.03 4.05 270.9%
Ev/FCF -26.07 20.97 -224.31%
E/P 0 1.63 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-370.83 25.2 -1571.61% -234.84 +57.91%
ROE -177.37 12.46 -1523.02%
ROA -35.63 6.23 -671.79%
ROIC 0 15.34 -100%
ROS -391.67 12.71 -3181.76%
ROCE -557 14.68 -3893.89%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.661 6.22 -110.63% -1.61 -58.87%
Nеt Debt/Ebitda 0.7547 -3.47 -121.73%
Debt/Ratio 0.2791 0.2246 24.24%
Debt/Equity 11.65 1 1063.33%
Debt/Net Income -0.6259 18.36 -103.41%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.28 -100% 0 0%
Number of years of dividend growth 0 1.59 -100%
DSI 0 0.7935 -100%
Average dividend growth 0 -303.64 -100%
Average percentage for 5 years 0 2.59 -100%
Average percentage for payments 0 167.32 -100%
Difference from average difference in sector -2.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-71.49 -98.5 -27.42%
Growth impulse Ebitda in 5 years -239.43 -98.62 142.78%
Growth impulse Net Income in 5 years -0.7042 -98.32 -99.28%
Growth impulse FCF in 5 years -85.18 -98.32 -13.36%
Growth impulse EPS in 5 years -3.43 -82.03 -95.82%
IP Score
2.04/10

Similar companies

Innovent Biologics, Inc.

Bayport International Holdings, Inc.

Cannonau Corp.

Abcam plc

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription